Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa).

Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa).

Item
http://www.wikidata.org/entity/Q34226250
Papanicolaou smears and cervical inflammatory cytokine responses.Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: a case-control study.Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies.Determinants of sexual activity and its relation to cervical cancer risk among South African womenFas and FasL gene polymorphisms are not associated with cervical cancer but differ among Black and Mixed-ancestry South AfricansCCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.Smoking habit, immune suppression, oral contraceptive use, and hormone replacement therapy use and cervical carcinogenesis: a review of the literature.The relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population.The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South AfricaCervical human papillomavirus (HPV) infection and HPV type 16 antibodies in South African women.Cervical human papillomavirus (HPV) infection in South African women: implications for HPV screening and vaccine strategiesDepot-medroxyprogesterone acetate and combined oral contraceptive use and cervical neoplasia among women with oncogenic human papillomavirus infectionInjectable and oral contraception and the incidence and progression of cervical disease in HIV-infected women in South Africa.Is oral contraceptive use associated with an increased risk of cervical cancer? An evidence-based meta-analysis.CASP8 promoter polymorphism is associated with high-risk HPV types and abnormal cytology but not with cervical cancer.
P2860

Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa).

Item
http://www.wikidata.org/entity/Q34226250
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Risk of invasive cancer of the ...... contraceptives (South Africa).
@ast
Risk of invasive cancer of the ...... contraceptives (South Africa).
@en
Risk of invasive cancer of the ...... rogestogen oral contraceptives
@nl
type
label
Risk of invasive cancer of the ...... contraceptives (South Africa).
@ast
Risk of invasive cancer of the ...... contraceptives (South Africa).
@en
Risk of invasive cancer of the ...... rogestogen oral contraceptives
@nl
prefLabel
Risk of invasive cancer of the ...... contraceptives (South Africa).
@ast
Risk of invasive cancer of the ...... contraceptives (South Africa).
@en
Risk of invasive cancer of the ...... rogestogen oral contraceptives
@nl
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921
P356
P1433
P1476
Risk of invasive cancer of the ...... contraceptives (South Africa)
@en
P2093
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P921